Prospective Canadian Trial In Newly Diagnosed Multiple Myeloma Patients with t(4;14): Bortezomib-Based Therapy without ASCT

被引：0

作者：

Reece, Donna E.

Rodriguez, Giovanni Piza ^{[1
]}

Belch, Andrew ^{[2
]}

Szwajcer, David ^{[3
,4
]}

Kovacs, Michael J. ^{[5
]}

Shustik, Chaim ^{[6
]}

Bahlis, Nizar J. ^{[7
]}

White, Darrell J. ^{[8
]}

Pantoja, Mariela ^{[1
]}

Chen, Christine

Kukreti, Vishal

Anglin, Peter ^{[9
]}

Trudel, Suzanne ^{[10
]}

机构：

[1] Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M4X 1K9, Canada

[2] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada

[3] CancerCare Manitoba, Dept Hematol, Winnipeg, MB, Canada

[4] Univ Manitoba, Winnipeg, MB, Canada

[5] Victoria Hosp, London Hlth Sci Ctr, London, ON N6A 4G5, Canada

[6] McGill Univ, Div Haematol, Ctr Hlth, Montreal, PQ, Canada

[7] Univ Calgary, Div Hematol, Calgary, AB, Canada

[8] Queen Elizabeth 2 Hlth Sci Ctr, Div Hematol, Halifax, NS, Canada

[9] Southlake Reg Canc Ctr, Newmarket, ON, Canada

[10] Princess Margaret Hosp, McLaughlin Ctr Mol Med, Toronto, ON M4X 1K9, Canada

来源：

BLOOD | 2010年 / 116卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：822 / 822

页数：1

共 50 条

[21] CONSOLIDATION WITH BORTEZOMIB AND LENALIDOMIDE POST-ASCT WITHOUT DEXAMETHASONE AND BISPHOSPHONATES: FINAL ANALYSIS OF A PROSPECTIVE STUDY IN NEWLY DIAGNOSED MYELOMA PATIENTS
Terpos, E.
Kastritis, E.
Christoulas, D.
Eleutherakis-Papaiakovou, E.
Gavriatopoulou, M.
Fotiou, D.
Panagiotidis, I.
Ziogas, D.
Kafantari, E.
Migkou, M.
Roussou, M.
Dimopoulos, M. A.
HAEMATOLOGICA, 2016, 101 : 86 - 87
[22] Clinical Outcomes According to Genomic Abnormalities in 566 Newly Diagnosed Multiple Myeloma Patients Treated with Bortezomib-Based Regimens
Cavo, Michele
Bringhen, Sara
Testoni, Nicoletta
Omede, Paola
Marzocchi, Giulia
Ruggeri, Marina
Durante, Sandra
Di Raimondo, Francesco
Rossi, Davide
Gorgone, Ausilia
Patriarca, Francesca
Petrucci, Maria Teresa
Buttignol, Silvia
Levi, Anna
Offidani, Massimo
Nozzoli, Chiara
Ria, Roberto
Olivero, Barbara
Galli, Monica
Montefusco, Vittorio
Callea, Vincenzo
Falcone, Antonietta
De Vivo, Antonio
Boccadoro, Mafio
Terragna, Carolina
Palumbo, Antonio
BLOOD, 2009, 114 (22) : 741 - 741
[23] Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM
Tang, Hoi Ki Karen
Fung, Chi Yeung
Hwang, Yu Yan
Lee, Harold
Lau, Grace
Yip, Sze Fai
Kho, Bonnie
Lau, Chi Kuen
Leung, Kwan Hung
Au, Elaine
Tse, Eric
Sim, Joycelyn
Kwong, Yok Lam
Chim, Chor Sang
BONE MARROW TRANSPLANTATION, 2024, 59 (05) : 660 - 669
[24] Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
Richardson, Paul G.
Weller, Edie
Lonial, Sagar
Jakubowiak, Andrzej J.
Jagannath, Sundar
Raje, Noopur S.
Avigan, David E.
Xie, Wanling
Ghobrial, Irene M.
Schlossman, Robert L.
Mazumder, Amitabha
Munshi, Nikhil C.
Vesole, David H.
Joyce, Robin
Kaufman, Jonathan L.
Doss, Deborah
Warren, Diane L.
Lunde, Laura E.
Kaster, Sarah
DeLaney, Carol
Hideshima, Teru
Mitsiades, Constantine S.
Knight, Robert
Esseltine, Dixie-Lee
Anderson, Kenneth C.
BLOOD, 2010, 116 (05) : 679 - 686
[25] Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma
Mai, Elias K.
Hielscher, Thomas
Bertsch, Uta
Schlenzka, Jana
Salwender, Hans J.
Munder, Markus
Gerecke, Christian
Duehrsen, Ulrich
Brossart, Peter
Neben, Kai
Hillengass, Jens
Raab, Marc S.
Merz, Maximilian
Baertsch, Marc-Andrea
Jauch, Anna
Hose, Dirk
Martin, Hans
Lindemann, Hans-Walter
Blau, Igor W.
Scheid, Christof
Weisel, Katja C.
Goldschmidt, Hartmut
LEUKEMIA, 2019, 33 (01) : 258 - 261
[26] Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma
Elias K. Mai
Thomas Hielscher
Uta Bertsch
Jana Schlenzka
Hans J. Salwender
Markus Munder
Christian Gerecke
Ulrich Dührsen
Peter Brossart
Kai Neben
Jens Hillengass
Marc S. Raab
Maximilian Merz
Marc-Andrea Baertsch
Anna Jauch
Dirk Hose
Hans Martin
Hans-Walter Lindemann
Igor W. Blau
Christof Scheid
Katja C. Weisel
Hartmut Goldschmidt
Leukemia, 2019, 33 : 258 - 261
[27] Thrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma
Chan, Kah-Lok
Filshie, Robin
Nandurkar, Harshal
Quach, Hang
LEUKEMIA & LYMPHOMA, 2015, 56 (07) : 2185 - 2186
[28] Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
Robak, Tadeusz
Huang, Huiqiang
Jin, Jie
Zhu, Jun
Liu, Ting
Samoilova, Olga
Pylypenko, Halyna
Verhoef, Gregor
Siritanaratkul, Noppadol
Osmanov, Evgenii
Alexeeva, Julia
Pereira, Juliana
Drach, Johannes
Mayer, Jiri
Hong, Xiaonan
Okamoto, Rumiko
Pei, Lixia
Rooney, Brendan
van de Velde, Helgi
Cavalli, Franco
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (10): : 944 - 953
[29] Bortezomib-Based Induction Treatments Improve Outcomes of Newly Diagnosed Multiple Myeloma Patients with High-Risk Cytogenetic Abnormalities
Cavo, Michele
Bringhen, Sara
Terragna, Carolina
Omede, Paola
Marzocchi, Giulia
Ruggeri, Marina
Durante, Sandra
Petrucci, Maria Teresa
Guglielmelli, Tommasina
Benevolo, Giulia
Montefusco, Vittorio
Narni, Franco
Falcone, Antonietta
Califano, Catello
Baraldi, Anna
Pasini, Silvana
Galieni, Piero
Morabito, Fortunato
Grasso, Mariella
Gottardi, Daniela
Rizzo, Vincenzo
Boccadoro, Mario
Testoni, Nicoletta
Palumbo, Antonio
BLOOD, 2010, 116 (21) : 342 - 343
[30] Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment
Zannetti, Beatrice Anna
Zamagni, Elena
Santostefano, Marisa
De Sanctis, Lucia Barbara
Tacchetti, Paola
Mancini, Elena
Pantani, Lucia
Brioli, Annamaria
Rizzo, Raffaella
Mancuso, Katia
Rocchi, Serena
Pezzi, Annalisa
Borsi, Enrica
Terragna, Carolina
Marzocchi, Giulia
Santoro, Antonio
Cavo, Michele
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (07) : 647 - 652

← 1 2 3 4 5 →